WalkFit, LLC Participates In ERSP Forum

New York, NY – August 5, 2005 – The Electronic Retailing Self-Regulation Program (ERSP), the electronic direct-response industry’s self-regulatory forum supervised by the National Advertising Review Council (NARC), announced that WalkFit, LLC (“WalkFit”), marketers of the WalkFit Orthotics, provided a reasonable basis for their advertising and will inform consumers about available shoe sizes in future advertising edits. The marketer’s advertising was reviewed pursuant to ERSP’s ongoing monitoring program.

ERSP asked WalkFit, LLC to provide substantiation for core claims (i.e., “Independent clinical study conducted by doctors over 90% got pain relief in their foot, knees, hips, and back…”; “Immediate help.“; “I have not had to go back to physical therapy.”) and to add a disclosure for diabetes patients to its 30- minute infomercial.

ERSP determined that WalkFit provided a reasonable basis for the core efficacy claims made during the infomercial. The company submitted a clinical study, which indicated that more than 90 percent of subjects received pain relief after use of the WalkFit insoles. ERSP had inquired about the claim “great for kids,” but was satisfied by WalkFit’s stated intent to provide information on available sizes at its call centers and in future editions of the infomercial. ERSP determined that testimonials included in the infomercial, which already contained disclosures, were supported by the study. Finally, ERSP was satisfied that the disclosure relating to diabetes, when displayed prominently on product packaging, adequately alerted consumers with this condition to seek a doctor’s approval before wear.

WalkFit, in response to the ERSP decision, announced it “is pleased that ERSP has concluded that the
…claims for WalkFit™ orthotics have been fully and properly substantiated… WalkFit is a strong
supporter of the ERSP process and appreciates ERSP’s thorough review and consideration of this program and of the substantiation data provided by WalkFit.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

NAD Finds Certain Claims for Mott’s Fruit Flavored Snacks Supported or Outside NAD’s Jurisdiction; Recommends General Mills Discontinue or Modify Other Claims

New York, NY – November 25, 2024 – The National Advertising Division recommended that General Mills discontinue or modify certain express and implied claims regarding the fruit and vegetable content of Mott’s Fruit Flavored Snacks and the nutritional benefits of those ingredients.

Read the Decision Summary
Decision

In National Advertising Division Challenge, Drip Hydration Voluntarily Discontinues Claims for its Ketamine IV Therapy

New York, NY – November 22, 2024 – Following a challenge brought by the National Advertising Division as part of its routine monitoring program, Drip Hydration voluntarily discontinued advertising claims for its Drip Hydration Ketamine IV Therapy.

Read the Decision Summary
Decision

NAD Finds Patented and Safety Claims for POOPH’s Pet Odor & Stain Eliminator Supported; Recommends Other Claims Be Modified or Discontinued

New York, NY – November 21, 2024 – The National Advertising Division determined that Ikigai supported patented and safety claims for their POOPH Pet Odor & Stain Eliminator, but recommended that other claims, including claims that POOPH eliminates odors and strains, be discontinued.

Read the Decision Summary
Decision

National Advertising Division Recommends SharkNinja Discontinue Certain Best Deep Carpet Cleaning Claims

New York, NY – November 19, 2024 – BBB National Programs’ National Advertising Division recommended that SharkNinja discontinue the claim “The Best Deep Carpet Cleaning Among Full-Sized Deep Carpet Cleaners** Based on ASTM F2828 vs. full-sized carpet cleaners above 14 lbs.”     

Read the Decision Summary